Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines.
Healthy adults (n=330) were randomized to receive either a bivalent vaccine composed of Vibrio cholerae CVD 103-HgR and Salmonella typhi Ty21a or a placebo. The combined vaccine was well tolerated. Approximately 80% of vaccines manifested a significant rise in anti-S. typhi immunoglobulin G or immun...
Guardado en:
| Publicado en: | Infect Immun |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1996
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC173943/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8606118/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.64.4.1454-1457.1996 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|